New sling offers hope for women with stress incontinence

NCT ID NCT04115605

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 598 women who received the Altis Single Incision Sling, a minimally invasive mesh device, to treat stress urinary incontinence. Researchers tracked how well the sling worked and monitored safety over 12 and 36 months after implantation. The goal was to see if the device improves symptoms and has an acceptable safety profile in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Altis Single Incision Sling (a permanently implanted synthetic mesh sling)
What this could lead to
If successful, this could confirm that the Altis sling is a safe and effective long-term option for controlling stress urinary incontinence in women.
What could go wrong
The study was terminated early, so results may be incomplete. As an observational study, it cannot prove cause and effect, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMALE STRESS URINARY INCONTINENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Armand Brillart Hospital

    Nogent-sur-Marne, 94130, France

  • Azienda USL Valle d'Aosta

    Aosta, 11100, Italy

  • CH Libourne

    Libourne, 33500, France

  • CH Paul Ardier

    Issoire, 63503, France

  • CHI Poissy Saint Germain en Laye

    Poissy, 78303, France

  • CHRU Hotel Dieu

    Angers, 49933, France

  • CHU Clermont Ferrand

    Clermont-Ferrand, 63003, France

  • CHU Pellegrin-Urology Departement

    Bordeaux, 33076, France

  • CHU Pellegrin_Gyneacology Departement

    Bordeaux, 33076, France

  • Centre Clinical

    Soyaux, 16800, France

  • Centre Hospitalier Saint Louis

    La Rochelle, 17019, France

  • Clinique Ambroise Paré

    Toulouse, 31082, France

  • Clinique Champeau Mediterranée

    Béziers, 34535, France

  • Clinique Mutualiste de la Porte de l'Orient

    Lorient, 56100, France

  • Clinique Rhône Durance

    Avignon, 84082, France

  • Clinique Saint Jean Languedoc

    Toulouse, 31077, France

  • Clinique Saint-Amé

    Lambres-lez-Douai, 59552, France

  • Clinique Saint-Charles

    La Roche-sur-Yon, 85106, France

  • Clinique St Hilaire

    Rouen, 76044, France

  • Clinique du Mail La Rochelle

    La Rochelle, 17087, France

  • Frauenärzte im Seenland

    Gunzenhausen, 91710, Germany

  • Hosital Clinico de Valladolid

    Valladolid, 47003, Spain

  • Hospital Univeritario Joan XXIII

    Tarragona, 43005, Spain

  • Hospital Vall d'Hebron

    Barcelona, 08035, Spain

  • Hospital la Fé

    Valencia, 46026, Spain

  • Hôpital Victor Jousselin

    Dreux, 28102, France

  • Hôpital du Pays d'Autan

    Castres, 81108, France

  • Hôpital privé Jacques Cartier

    Massy, 91349, France

  • Klinikum Memmingen

    Memmingen, 87700, Germany

  • Klinikum Worms gGmbH

    Worms, 67550, Germany

  • Polyclinique Jean Villars

    Bruges, 33523, France

  • Pôle Santé Léonard de Vinci

    Chambray-lès-Tours, 37170, France

  • UZ Leuven

    Leuven, 3000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.